Sexually transmitted diseases (STDs) are leading causes of substantial morbidity worldwide. Identification of risk factors for estimating STD risk provides opportunities for optimising service delivery in clinical settings, including improving case finding accuracy and increasing cost-efficiency by limiting the testing of low-risk individuals. The current study was undertaken to synthesise the evidence supporting commonly cited chlamydia and gonorrhoea risk factors. The level of empirical support for the following predictors was strong/moderate: age, race/ethnicity, multiple lifetime sexual partners, sex with symptomatic partners and concurrent STD diagnosis. The following predictors had weak evidence: socio-economic status, transactional sex, drug/alcohol use, condom use and history of STD diagnosis. The most frequently listed predictors among nine clinical guidelines were younger age and multiple sexual partners; the least consistently listed predictor was inconsistent condom use. We found reasonably good concordance between risk factors consistently listed in the recommendations and predictors found to have strong empirical support in the literature. There is a need to continue building the evidence base to explicate the mechanisms and pathways of STD acquisition. We recommend periodic reviews of the level of support of predictors included in clinical guidelines to ensure that they are in accordance with empirical evidence.
Introduction
Sexually transmitted diseases (STDs) such as chlamydia and gonorrhoea are leading causes of substantial morbidity worldwide; left untreated, they are often important exposures in the causal pathway for pelvic inflammatory disease, ectopic pregnancies and infertility. In many countries, publicly-funded sexual and reproductive health (SRH) clinics are tasked with providing free or low-cost STD testing and treatment services. However, the recent economic downturn, budgetary shortfalls and cutbacks to public health infrastructure have resulted in SRH clinics operating at maximum capacity with limited resources. 1, 2 Concomitantly, there has been a shift towards the development of alternative models of service delivery in SRH clinics focused on patient-centred care and cost-effectiveness (e.g. Internet-based STD testing; self-collected specimens), 3, 4 including providing 'express visit' options to asymptomatic patients in SRH clinics who are deemed to be at low STD risk, during which these patients do not undergo physical examination but are offered testing only. 5, 6 Because these alternative service delivery options involve patients having limited interactions with clinicians, another mechanism for recommending tests and triaging patients is required. There is, however, limited guidance in the literature about how to selectively test a those at highest risk for STDs in the absence of clinician interaction.
Identification of risk factors predictive of STD risk provides the opportunity to deliver four key benefits in clinical settings: identifying specific patient groups with higher disease prevalence, identifying areas to target prevention services, improving case-finding accuracy, and increasing cost-efficiency by limiting the testing of low-risk individuals. Plausible candidates for selective testing criteria include known determinants of prevalent infection (e.g. age, multiple partners). 7 However, predictors used for selective testing are often derived from clinical guidelines that are broadly perceived as evidence-based statements; because they are developed by experts, they are assumed to have the same level of certainty and authority as conclusions generated by scientific methods. 7, 8 Few studies have been conducted to determine the degree to which evidence in the published literature supports the predictors included in recommendations. A better understanding of the use (or lack) of evidence in this area has the potential to inform the ways in which STD test recommendation practices unfold in the future.
The current study was undertaken to synthesise the evidence-supporting predictors of chlamydia and gonorrhoea (the two most common reportable STDs) in high-income jurisdictions in North America, Western Europe and Australia -regions with comparable STD prevalence and social determinants of sexual health. The objectives are to identify risk factors cited as being most predictive of chlamydia and gonorrhoea in clinical guidelines and in empirical studies. We also aimed to assess the strength of evidence supporting the association between these predictors and chlamydia and gonorrhoea outcomes in empirical studies. Finally, we highlight discrepancies between predictors used in STD clinical guidelines and the relevant empirical evidence.
Methods

Literature search
We identified the most recent and commonly cited clinical guidelines for screening chlamydia and gonorrhoea issued by health organisations in high-income countries in North America and Europe, and Australia. We also identified empirical studies in journals readily accessible to SRH clinicians or experts in these settings and thus limited our search to electronic searches of Englishlanguage studies published in OVID Medline, as well as manual searches of reference lists of papers identified. MeSH search terms included 'screening', and at least one of 'chlamydia', 'gonorrhoea', 'STI' or 'STD'. Articles that measured demographical and behavioural predictors associated with STD diagnoses were included. Studies focusing on psychosocial factors (e.g., knowledge and attitudes, stress, self-esteem) were excluded, as these predictors are not consistently measured across studies. STD signs and symptoms were not examined as they are clearly indicative of infection. The search was limited to studies published 2003-2011, an era characterised by the expansion of highly-sensitive tests (e.g. Nucleic Acid Amplification Tests) and urinebased testing, in an effort to ensure comparability in specimen collection and STD outcome assessment.
Assessment of methodological quality
Articles selected for inclusion were examined to assess their methodological quality. The following nine criteria 9,10 were used to score the methodological quality of studies: study design, specimen collection, statistical methods, model selection, study sample description, variable definition, events per variable, outcome assessment and study generalisability (see Table 1 ). Based on the scoring system, studies with a rating of 'unacceptable' (3 points) were removed from further review. Studies rated as 'marginal' (4-5 points), 'acceptable' (6-7 points) and 'commendable' (8-9 points) were kept for empirical analysis stage of the review. The studies rated as 'commendable' or 'acceptable' were given greater weight when interpreting consistency or variable relationships.
Data extraction
To help clarify the relative strength or importance of each STD predictor, we categorised the predictors extracted from the empirical studies into two groups based on the proximate-determinants framework: 11, 12 (1) proximate determinants, which are demographic, social or economic variables distally related to STDs, and (2) proximate determinants, which are directly associated with an individual's probability of exposure to STDs and the efficiency of STD transmission. Also, to determine whether the various factors identified in the included studies were significantly associated with STDs in multivariable analysis (if possible), a significance level of 0.05 was used. Because the studies included in this review were heterogeneous with respect to study design and predictor definition, pooling of data for meta-analyses was not possible. Therefore, a qualitative data-synthesis was performed. 13,14 a We use the phrase ''selective testing'' instead of ''selective screening'' because most studies in this review included individuals with STD signs and symptoms. By definition, only asymptomatic individuals are considered for screening purposes. Key predictors mentioned in multiple studies were retained to test the level of empirical support for their association with chlamydia or gonorrhoea infection (STDs). The strengths of the evidence for predictors were assessed as follows: 13 (1) strong evidence: >75% of multiple 'acceptable' or 'commendable' studies found consistent and statistically significant greater risk of infection; (2) moderate evidence: 60-74% of multiple 'acceptable' or 'commendable' studies found consistent and statistically significant greater risk of infection; (3) inconclusive evidence: 45-59% of multiple 'acceptable' or 'commendable' studies found consistent and statistically significant greater risk of infection; (4) weak evidence: <45% of 'acceptable' or 'commendable' studies found consistent and statistically significant greater risk of infection. In addition, predictors were also deemed to have insufficient evidence if few studies (i.e. less than the lowest quartile of the number of studies reviewed) examined the association between the predictor and infection.
Results
Overview of clinical guidelines
We identified nine organisations issuing clinical guidelines in high-income contexts ( Table 2 ). Six organisations listed clinical guidelines for women only, citing lack of evidence for the selective screening of men: the US Preventive Services Task Force (USPSTF), 15, 16 the American Academy of Family Practice (AAFP), 15, 16 the US Centers for Disease Control and Prevention (USCDC), 17 the American College of Obstetrics and Gynecology (ACOG), 18 the Public Health Agency of Canada (PHAC) 19 and the Society of Obstetricians and Gynecologists (SOGC) 20 (Table 2) . Three other organisations reported clinical guidelines for men and women combined. [21] [22] [23] Almost all the organisations support the universal screening of young sexually-active individuals for chlamydia and to some extent gonorrhoea (Table 2) . Occasionally, clinical guidelines differ across organisations, mainly because of distinctions in mission and target audience 24 as well as the epidemiology of the various STDs. For example, the USCDC and PHAC focus on population health in the US and Canada, respectively, while other organisations focus on the clinical settings. 24 A closer examination of predictors revealed incongruities between the organisations, even among those in the same country ( Table 2 ). For example, clinical recommendations issued by both the PHAC and the SOGC agree on screening individuals with the following risk factors for chlamydia or gonorrhoea infection: younger age, sexual contact of STD case, previous STD diagnosis, new sexual partners, multiple sexual partners, use of drugs or alcohol during sex, sex in exchange for money or gifts, and Table 1 . A summary of the criteria to be used to evaluate and rate the quality of methodology for each study. a
Element
Quality of methodology criteria
A. Study design
The study design was clearly evident (e.g. cross-sectional, cohort or case-control) B. Specimen collection The specimen collection methodology was clearly defined. If the same specimen collection methodology was not used consistently among study participants, methods to adjust for this difference were included in the analyses.
C. Statistical methods
Multivariate analyses were used to examine the relationship between predictors and STD outcome. Methods used to examine subgroups and interactions were stated D. Model selection A clear attempt at model selection was made.
Step-wise procedures or an a priori specification of p-value cutoff points for variable inclusion were considered acceptable for this criterion E. Study sample description
The characteristics of the sample and the selection criteria for the study were clearly stated such as: location, time period, sampling method, sample size, entry criteria and exclusions. The study also included a description of non-respondents. The extent and nature of missing data were assessed to estimate potential bias.
F. Variable definition
Sources of data and details of methods of assessment were given for each variable.
G. Events per variable
The final sample size that was actually used in the analysis comprised of 10 study outcomes per variable. H. Outcome assessment STD outcomes were measured by the most sensitive and specific tests available at the time of data collection. I. Study generalisability STD screening was evaluated in an appropriate spectrum of subjects and sampling was based upon a multicentre study or involved a single study with a relatively large sample size of consecutive visits to a clinic. a Each quality criterion was awarded one point whenever present. Overall ratings were calculated by totaling the points and designated as commendable (8-9 points), acceptable (6-7 points), marginal (4-5 points) and unacceptable (3 points). individuals or travellers from endemic regions ( Table 2 ). However, the PHAC also identifies the following risk factors: street involvement (or homelessness) and sexual contacts of people with any of the aforementioned risk factors ( Table 2) . The most consistently listed predictors among clinical recommendations were younger age and multiple sexual partners as all nine organisations recommended screening individuals with these two risk factors (Table 2) . Approximately, 90% of the nine organisations recommended screening individuals who are sexual contacts of STD cases and also those who use alcohol or drugs during sexual relations. The least consistently listed predictors were street involvement (11%), inconsistent condom use (44%) and individuals or travellers from STD endemic regions (56%).
Assessment of included studies
Based on the article-selection process listed in Figure 1 , 75 studies were rated, most of which included a mix of symptomatic and asymptomatic individuals (Table 3) . Approximately, 68% of studies examined chlamydia infection only, 8% examined gonorrhoea outcomes only and 19% examined both outcomes (Table 3) . Approximately, 32% of the studies had women-only populations and 20% included men-only populations. Nearly 50% were from the USA (Table 3 ). Some studies used population-based participant recruitment (21%), and most studies were cross-sectional in design (87%). A minority of the studies examined only asymptomatic populations (8%). Based on the nine criteria of methodological quality, a total of five studies (7%) received a score of 3/9 and thus were rated as 'unacceptable'. [25] [26] [27] [28] [29] These studies were omitted from the second stage of review. Studies rated as 'marginal' (24%), 7,30-46 'acceptable' (41%) and 'commendable' (28%) 4, [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] were retained in the review. Table 4 summarises the 70 studies that were retained for further assessment.
Empirical support for the following seven variables was strong or moderately strong: age (at time of study), race/ethnicity, multiple lifetime sexual partners, multiple sexual partners in recent months, sex with infected partners, sex with symptomatic partners and concurrent STD diagnosis. Three predictors had inconclusive evidence: age at sexual debut, sex with causal partners and sex with new partners. Eight predictors had weak evidence associating them with STD diagnosis: socioeconomic status, marital status, sexual partners from overseas, sex in exchange for gifts/money, drug/alcohol use, condom use, sex with regular partners and history of STD diagnosis.
Predictors examined by 11 studies or less (i.e. less than the lowest quartile of the number of studies reviewed) were deemed to have insufficient research. There were insufficient empirical studies to determine the nature of the association between the following six
Step 1
Initial search of database 841 articles identified
Step 2
Review of titles and keywords of all articles 216 articles found to be relevant to study 74 articles found to be relevant and consistent with inclusion criteria of the study
Step 3
Review of abstracts of all relevant articles 56 articles found to be relevant to study objectives and consistent with inclusion criteria of study
Step variables and infection: sex in exchange for gifts/ money, sexual partners from overseas, sex with regular partners, sex with casual partners, concurrent STD diagnosis and sex with symptomatic partners. Six variables were not included in any clinical guidelines: race/ ethnicity, socio-economic status, marital status, sex with regular partners, sex with casual partners and sex with symptomatic partner.
Assessment of the predictive abilities of underlying determinants
The following underlying determinants of STD diagnosis were identified in this review: age (at study time), age at sexual debut, race/ethnicity, socio-economic status (SES), sex work, marital status and drug/alcohol use (Table 4 ). Younger age was consistently associated with increased risk of STD acquisition (especially chlamydia infection); 85% of 'commendable' studies reported a significant association between age and STD diagnosis in their multivariable analyses (Table 4 ). There was inconclusive evidence in the current review associating early age at sexual debut to STD diagnosis; only 25% of 'commendable' studies and 56% of 'acceptable' studies that examined this risk factor found a significant relationship between age at sexual debut and STD diagnosis ( Table 4 ). The level of empirical evidence in the current review for the association between race/ethnicity and STD diagnosis was moderate: 72% of 'commendable' studies and 68% of 'acceptable' studies measuring this association found significant associations in their multivariable analyses ( Table 4 ). Most of these studies found a higher risk of infection among ethnic minority individuals in multivariate analysis. 4, 86 Conversely, the level of empirical evidence of the association between SES and STD diagnosis was rated as weak -only 56% of 'commendable' studies and 18% 'acceptable' studies found a significant relationship (Table 4 ). SES was not associated with infection in multivariable analyses using any measure, including educational level 66, 87, 94 and employment status. 48, 57 This review found weak evidence for the association between STD diagnosis and the following predictors: drug/alcohol use and sex in exchange for drugs/ money ( Table 4 ). Only 33% of 'commendable' studies and 33% of 'acceptable' studies found associations between drug/alcohol use and STD diagnosis.
Assessment of the predictive abilities of determinants of exposure of susceptible to infected people
The following proximate determinants of exposure to infected people were identified in this review: multiple lifetime sexual partners, multiple sex partners in recent months, sexual partners from overseas, sex with regular partners, sex with casual partners, sex with new partners, sex with infected partners and sex with symptomatic partners ( Table 4 ). The empirical evidence linking multiple lifetime sexual partners (i.e. more than one sexual partner) and STDs was strong. However, there was no consistent evidence for the association with higher cut-points (e.g. >2, >5, or >10 partners). All of the 'commendable' studies and 57% of 'acceptable' studies showed significant associations between multiple lifetime sexual partners and STD diagnosis ( Table 4 ). We also found strong evidence for the association between having multiple sexual partners in recent months and STD diagnosis. Approximately, 64% of 'commendable' studies and 57% of 'acceptable' studies that measured this relationship found a significant association between having multiple sexual partners in recent months in multivariable analysis (Table 4 ). This review also explored the association between STD diagnosis and sexual partner characteristics. The evidence for the association between STD diagnosis and the following predictors was either inconclusive, weak and/or explored in few studies: sex with regular partners, sex with casual partners and sex with partners from overseas (Table 4 ). We found inconclusive evidence regarding the association between having a new partner and STD diagnosis (only about 60% of 'commendable' studies and 33% of 'acceptable' studies that measured this variable found significant associations with STD diagnosis). This review found strong evidence between STD diagnosis and sex with infected partners or symptomatic partners. All of the 'commendable' studies and 75% of 'acceptable' studies measuring this association between found a significant association.
Assessment of the predictive abilities of determinants of the efficiency of transmission
The following proximate determinants of the efficiency of infection transmission were identified: history of STD diagnosis, concurrent STD diagnosis and condom use (Table 4 ). We found weak evidence for the association between having a history of STD diagnosis and infection. Only 33% of 'commendable' studies and 45% of 22 'acceptable' studies that measured this association found a significant relationship between history of STD diagnosis and STD diagnosis in multivariable analyses. There was, however, strong evidence for the association between having a concurrent STD diagnosis and infection. Both of the two 'commendable' studies and 75% of the four 'acceptable' studies that explored the relationship between having a concurrent STD diagnosis and infection found a significant association, although few studies explored this relationship (n ¼ 11).
The empirical evidence for the association between the use of condoms and infection was weak across the studies. Only 36% of 'commendable' studies, 26% of 'acceptable' studies and 25% of 'marginal' studies found significant associations between condom use and STD diagnosis. There were no notable trends among the studies examining the relationship between condom use and STD diagnosis, although self-reported condom use is an enduring measurement problem in this field. 98 
Discussion
The increasing availability and use of non-invasive diagnostic tests for STD diagnosis has reopened discussions about the feasibility of scaling up selective testing efforts to include the general population. Thus, a better understanding of the availability (or lack) of evidence in this area may help inform the ways in which existing selective testing criteria continue to be implemented as well as the potential for novel approaches to STD testing intervention practices to unfold in the future, including Internet-based testing initiatives. 99 This review was conceptualised as a guide to help decisionmakers considering undertaking selective testing programmes in alternative settings such as the Internet; specifically, the findings may help them augment selective testing by identifying variables to include in risk assessment questionnaires.
This review accomplishes two tasks. First, it summarises the literature on the most consistent predictors of chlamydia and gonorrhoea infection, which were identified after a wide range of patient characteristics was assessed. Age, number of sexual partners, sex with a symptomatic partner, sex with an infected partner and concurrent STD diagnosis are perhaps the most intuitive predictors of STD risk. The current review has reinforced the importance of these variables. Second, this review adopted a theoretical framework to contextualise the findings. The proximate-determinants framework hypothesises that that after adjustment for the proximate determinants or socio-behavioural predictors, relationships between the underlying or socio-demographic characteristics and STD diagnosis should be non-significant. 11, 12 In this review, several underlying predictors (e.g. age and race/ethnicity) were found to be significantly associated with STD diagnosis even in studies that adjusted for proximate determinants. This finding suggests that some proximate determinants may potentially be measured with error. 11, 12 It also highlights the complexity inherent in the self-reported nature of proximate determinants such as condom use, coupled with measurement issues in underlying predictors (e.g. race/ ethnicity). 100 We found reasonably good concordance between risk factors consistently listed in the recommendations (e.g. younger age, multiple sexual partners and sexual contact of STD case) and predictors found to have strong empirical support in the literature (i.e. if a risk factor is included in more guidelines, then there is more evidence supporting its predictive capacity). However, when the guidelines are considered individually or in isolation, there are large inconsistencies between the STD risk factors cited by the organisations that may reflect the lack of clarity, transparency and consensus about how high-risk behaviours influence specific STD diagnosis. Another possible explanation for the differences in recommendations may be due to regional differences in prevalence. These inconsistencies could also reflect the overall priorities of organisations issuing recommendation statements (e.g. minimising harm from screening and cost-effectiveness versus concerns about missed cases).
This review has some limitations. There was a paucity of empirical studies examining the strength of predictors in asymptomatic populations. Because most STDs are asymptomatic, it is important to elucidate the predictive ability of risk factors in the absence of symptoms. However, most studies combined symptomatic and asymptomatic individuals in multivariable analyses likely masking important differences between these populations. We were unable to identify clear trends in associations between predictors and STDs among the six studies that explicitly examined asymptomatic populations. This limitation may have considerable impact on some findings. First, it is likely that the effect sizes of other predictors were underestimated in multivariable regression models that included symptoms as covariates because of the strong association between symptoms and STDs. Second, the significant associations between some predictors and STDs may be a function of selection bias in SRH clinic settings because of differential health-seeking behaviours. 101, 102 It is hypothesised that when health-seeking behaviour of certain population sub-groups (e.g. older adults, racial/ethnic minorities) is low, its percentage of symptomatic clinic visits will be high because these individuals are less likely to visit SRH clinic for routine screening. 101, 102 Thus, the associations found may not actually reflect a higher concentration of risk in certain sub-groups but is a reflection of the over-representation of these sub-groups in symptomatic populations presenting to clinics. Further studies assessing asymptomatic populations are, thus, warranted.
Also, we were unable to synthesise the evidence for predictors of chlamydia and gonorrhoea separately as there were few studies examining gonorrhoea outcomes only. Based on a sub-analysis, the most important predictors of gonorrhoea outcomes only were no different from those for chlamydia outcomes only, despite the differences in the epidemiology and social determinants between these two infections. In addition, we were unable to evaluate the extent of collinearity between predictors. However, a closer examination of model building in the individual articles revealed that most studies handled collinearity appropriately, e.g. including one of the collinear variables in the final model. We were unable to synthesise the evidence separately for special populations (e.g. men who have sex with men, men who have sex with women) as clinical guidelines and empirical analyses for these groups were inconsistently reported.
We would like to draw some attention to some differences in guideline recommendations for populationbased screening at general practitioner settings, for example compared to SRH clinics. The identification of high-risk individuals in these two settings requires slightly differently approaches to decision-making. For example, in order to reduce STD incidence on a population level, studies of disease dynamics recommend focusing screening efforts on core groups who are more likely to have the highest concentration of risk behaviours and infection incidence (e.g. adolescents, sex workers). [103] [104] [105] However, in STD clinic settings, where individual-level screening decision-making is the priority, the development of a personalised riskscoring tool may have more relevance. 61, 106 In the future, SRH clinicians may develop risk estimation or prediction tools by combining the risk factors identified in this review. The prediction tools may have important implications for targeted risk communication and STD testing motivation among patients attending SRH clinics. 107 Finally, we recommend that periodic reviews of the evolving evidence base in this substantive area have good potential to contribute to the planning and evaluation of selective testing intervention practices as they unfold in the future. There is, however, a need to continue to build the evidence base, particularly for special populations, and as STD testing intervention practices expand to non-traditional settings (e.g. the Internet; the home).
